Variant report
Variant | esv3338527 |
---|---|
Chromosome Location | chr9:22651452-22655650 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:1)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
(count:1 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-CDKN2B-5 | chr9:22651795-22652209 | NONHSAT130440 |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs368979228 | chr9:22651460-22651461 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs113942386 | chr9:22651478-22651479 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs541257286 | chr9:22651479-22651480 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs60326321 | chr9:22651484-22651485 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs561170184 | chr9:22651491-22651492 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs116026998 | chr9:22651513-22651514 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs550007634 | chr9:22651541-22651542 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs563797897 | chr9:22651554-22651555 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs61011155 | chr9:22651621-22651622 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs35099020 | chr9:22651623-22651624 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs35556552 | chr9:22651647-22651648 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs397813212 | chr9:22651652-22651653 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs374462696 | chr9:22651657-22651658 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs551081226 | chr9:22651700-22651701 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs563914754 | chr9:22651724-22651725 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs569733919 | chr9:22651725-22651726 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs571593234 | chr9:22651734-22651735 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs142423646 | chr9:22651788-22651789 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs10965411 | chr9:22651796-22651797 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
20 | rs556767549 | chr9:22651801-22651802 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
21 | rs112133796 | chr9:22651826-22651827 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
22 | rs78978266 | chr9:22651834-22651835 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
23 | rs146003322 | chr9:22651854-22651855 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
24 | rs375766333 | chr9:22651876-22651877 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
25 | rs16906451 | chr9:22651877-22651878 | Weak transcription Enhancers | lncRNA | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
26 | rs556033184 | chr9:22651882-22651883 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
27 | rs576080243 | chr9:22651898-22651899 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
28 | rs115762274 | chr9:22651945-22651946 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
29 | rs558109777 | chr9:22651957-22651958 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
30 | rs10117999 | chr9:22651989-22651990 | Weak transcription Enhancers | lncRNA | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
31 | rs112525216 | chr9:22652035-22652036 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
32 | rs200252675 | chr9:22652039-22652040 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
33 | rs377456926 | chr9:22652041-22652042 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
34 | rs561588969 | chr9:22652075-22652076 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
35 | rs138635229 | chr9:22652139-22652140 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
36 | rs184634275 | chr9:22652172-22652173 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
37 | rs188655373 | chr9:22652181-22652182 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
38 | rs532614674 | chr9:22652184-22652185 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
39 | rs141743582 | chr9:22652215-22652216 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs559799516 | chr9:22652260-22652261 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs552574679 | chr9:22652285-22652286 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs1414694 | chr9:22652308-22652309 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs370279785 | chr9:22652327-22652328 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs528454567 | chr9:22652333-22652334 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs547717188 | chr9:22652337-22652338 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs567548854 | chr9:22652364-22652365 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs144647709 | chr9:22652375-22652376 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs181392022 | chr9:22652405-22652406 | Weak transcription Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs148477910 | chr9:22652415-22652416 | Weak transcription Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs538369752 | chr9:22652439-22652440 | Weak transcription Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Glioblastoma multiforme | 21080181 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Breast cancer | 16608533 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Breast cancer | 16272173 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Breast cancer | 17133270 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Cervical cancer | 21063398 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Splenic marginal zone lymphoma | 18492102 | CNVD |
Melanoma | 18172304 | CNVD |
Biliary cancer | 19435499 | CNVD |
Gastric cancer | 21586687 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Myopathy | 18421352 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Acute lymphoblastic leukemia | 18957548 | CNVD |
Myeloproliferative neoplasm | 17564968 | CNVD |
Malignant meningioma | 17937814 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Glioma | 21971842 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 17603634 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Cutaneous squamous cell carcinomas | 19131950 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Chordoma | 18071362 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Chordoma | 21602918 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
Developmental delay | 19490664 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
microdeletion syndrome | 16199537 | CNVD |
Non-syndromic sensorineural hearing loss | 21987784 | CNVD |
Cancer | 20164919 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Non-syndromic sensorineural hearing loss | 21030649 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Lung cancer | 18438408 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Chronic myeloid leukemia | 21384125 | CNVD |
Breast cancer | 21785460 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Autism | 22495311 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Developmental delay | 21147756 | CNVD |
Pilocytic astrocytoma | 18670637 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Melanoma | 22183965 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Non-small cell lung cancer | 19010865 | CNVD |
Myoepithelioma | 18604193 | CNVD |
Cancer | 22183965 | CNVD |
Glioblastoma multiforme | 21569311 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Ewing''s sarcoma | 22429812 | CNVD |
Neuroblastoma | 21899760 | CNVD |
Glioblastoma multiforme | 19435819 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Cutaneous T-cell lymphoma | 21881587 | CNVD |
Glioblastoma multiforme | 22291905 | CNVD |
Lung cancer | 21911935 | CNVD |
Primary central nervous system lymphoma | 21088137 | CNVD |
head and neck squamous cell carcinoma | 21798897 | CNVD |
Cancer | 21253487 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Intracranial ependymoma | 16609018 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Glioblastoma multiforme | 21922591 | CNVD |
Acute lymphoblastic leukemia | 17443227 | CNVD |
Barrett''s adenocarcinoma | 18663352 | CNVD |
T-cell acute lymphoblastic leukemia | 19406988 | CNVD |
Urothelial cell carcinoma | 18451213 | CNVD |
Glioma | 17123091 | CNVD |
Mental retardation | 17124404 | CNVD |
Acute lymphoblastic leukemia | 19100363 | CNVD |
Acute lymphoblastic leukemia | 18768390 | CNVD |
Leukemia | 19602459 | CNVD |
Acute monocytic leukemia | 16498392 | CNVD |
Esophageal squamous carcinoma | 18405350 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Leukemia | 18688285 | CNVD |
T-cell acute lymphoblastic leukemia | 18185524 | CNVD |
Acute myeloid leukemia | 19651601 | CNVD |
Coronary Disease | 20032323 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Cancer | 21732550 | CNVD |
Gastric cancer | 22539939 | CNVD |
Cancer | 21183584 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Metastatic melanoma | 18483359 | CNVD |
Non-small cell lung cancer | 20864512 | CNVD |
Cervical cancer | 21062161 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Glioblastoma | 17090523 | CNVD |
Lung cancer | 16773561 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Bladder cancer | 19088036 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Melanoma | 16977458 | CNVD |
Glioblastoma multiforme | 17369134 | CNVD |
Chagasic megaesophagus | 20163722 | CNVD |
Melanoma | 19566914 | CNVD |
Squamous cell cancer | 19047905 | CNVD |
Lung adenocarcinoma | 19525976 | CNVD |
Lung cancer | 19525976 | CNVD |
Hodgkin''s lymphoma | 18179710 | CNVD |
Glioma | 20126413 | CNVD |
Melanoma | 17363583 | CNVD |
Glioblastoma multiforme | 19115005 | CNVD |
Glioblastoma multiforme | 21138945 | CNVD |
Adenoid cystic carcinoma | 18332873 | CNVD |
Cancer | 20581869 | CNVD |
Oral cancer | 22144094 | CNVD |
Barrett''s syndrome | 19417022 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Oral cancer | 21386901 | CNVD |
Breast cancer | 21364760 | CNVD |
Acute myeloid leukemia | 17237825 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
early-passage human iPS cells | 21368824 | CNVD |
Breast cancer | 21858162 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr9:22650000-22653800 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
2 | chr9:22650800-22652400 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
3 | chr9:22650800-22653200 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
4 | chr9:22651000-22652000 | Enhancers | Adipose Nuclei | Adipose |
5 | chr9:22651200-22657000 | Weak transcription | Skeletal Muscle Female | skeletal muscle |
6 | chr9:22652000-22656400 | Weak transcription | Adipose Nuclei | Adipose |
7 | chr9:22652400-22652600 | Flanking Active TSS | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
8 | chr9:22652600-22652800 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
9 | chr9:22652800-22653000 | Flanking Active TSS | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
10 | chr9:22653000-22653200 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
11 | chr9:22653200-22654600 | Weak transcription | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
12 | chr9:22653200-22655000 | Weak transcription | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
13 | chr9:22653800-22654000 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
14 | chr9:22654000-22654400 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
15 | chr9:22654200-22654800 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
16 | chr9:22654400-22655600 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
17 | chr9:22654600-22655000 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
18 | chr9:22654800-22657000 | Weak transcription | Liver | Liver |
19 | chr9:22654800-22663600 | Weak transcription | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
20 | chr9:22655000-22656200 | Weak transcription | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
21 | chr9:22655000-22657200 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
22 | chr9:22655600-22657000 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |